Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate
Xizang Haisco Pharmaceutical Group Co Ltd cash flow reinvestment rate. Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow Reinvestment Rate of 1.83x as of September 2025, reinvesting CN¥72.46 Million (capex CN¥72.46 Million ) from operating cash flow of CN¥39.68 Million. See Xizang Haisco Pharmaceutical Group Co Lt (002653) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Cash flow reinvestment rate of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. Historical reinvestment intensity for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Explore 002653 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (2008–2025)
Xizang Haisco Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 2008 to 2025. Year-by-year capital reinvestment analysis for Xizang Haisco Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Xizang Haisco Pharmaceutical Group Co Lt cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥494.23 Million | CN¥786.00 Million | CN¥331.98 Million | ▼ -49.3% |
| 2024 | 1.24x | CN¥548.28 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -28.0% |
| 2023 | 1.72x | CN¥774.20 Million | CN¥449.58 Million | CN¥391.01 Million | ▼ -81.1% |
| 2022 | 9.09x | CN¥859.79 Million | CN¥94.55 Million | CN¥700.17 Million | ▼ -78.1% |
| 2021 | 41.47x | CN¥1.48 Billion | CN¥35.80 Million | CN¥702.94 Million | ▲ +879.6% |
| 2020 | 4.23x | CN¥873.05 Million | CN¥206.21 Million | CN¥601.72 Million | ▲ +440.7% |
| 2019 | 0.78x | CN¥598.43 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -10.4% |
| 2018 | 0.87x | CN¥413.11 Million | CN¥472.61 Million | CN¥351.98 Million | ▼ -31.4% |
| 2017 | 1.27x | CN¥499.13 Million | CN¥391.81 Million | CN¥393.26 Million | ▲ +135.2% |
| 2016 | 0.54x | CN¥221.61 Million | CN¥409.20 Million | CN¥208.24 Million | ▼ -18.7% |
| 2015 | 0.67x | CN¥295.16 Million | CN¥443.03 Million | CN¥283.68 Million | ▲ +42.6% |
| 2014 | 0.47x | CN¥234.86 Million | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥163.98 Million | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥125.30 Million | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥117.72 Million | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥80.95 Million | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥24.01 Million | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥37.38 Million | CN¥94.45 Million | CN¥37.38 Million | — |